FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085485 [Registered on: 24/04/2025] Trial Registered Prospectively
Last Modified On: 05/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Preventive
Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effectiveness of chlorhexidine varnish and riboflavin in reducing oral bacteria in people with braces. 
Scientific Title of Study   COMPARING THE EFFICACY OF RIBOFLAVIN A PHOTOSENSITISING COMPOUND AND CHLORHEXIDINE VARNISH IN CONTROLLING ORAL MICROFLORA IN ORTHODONTIC PATIENTS A RANDOMISED CONTROLLED TRIAL  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SobikaS 
Designation  post graduate student (MDS) 
Affiliation  Sri venkateswara dental college and hospital 
Address  Room no 6, department of Orthodontics and Dentofacial Orthopedics, Sri Venkateswara Dental College and Hospital, off Old Mahabalipuram Road,thalambur, Chennai, Tamil Nadu 600130

Chennai
TAMIL NADU
600130
India 
Phone  9677497399  
Fax    
Email  sobika.sudhakar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Sumanth Rangarajan 
Designation  Professor 
Affiliation  Sri venkateswara dental college and hospital 
Address  Room no 6, department of Orthodontics and Dentofacial Orthopedics, Sri Venkateswara Dental College and Hospital, off Old Mahabalipuram Road,thalambur, Chennai, Tamil Nadu 600130

Chennai
TAMIL NADU
600130
India 
Phone  9952034634  
Fax    
Email  drsumanthranga@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Sumanth Rangarajan 
Designation  Professor 
Affiliation  Sri venkateswara dental college and hospital 
Address  Room no 6, department of Orthodontics and Dentofacial Orthopedics, Sri Venkateswara Dental College and Hospital, off Old Mahabalipuram Road,thalambur, Chennai, Tamil Nadu 600130

Chennai
TAMIL NADU
600130
India 
Phone  9952034634  
Fax    
Email  drsumanthranga@gmail.com  
 
Source of Monetary or Material Support  
SELF FUNDED 
 
Primary Sponsor  
Name  sobika.s 
Address  sri venkateswara dental college and hospital,off old mahabalipuram road,thalambur,near navalur,chennai 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SobikaS  sri venkateswara dental college and hospital  Room no 6, Department of Orthodontics and Dentofacial Orthopedics,Off old mahabalipuram road,thalambur, chennai, tamilnadu 600130 Kancheepuram TAMIL NADU
Chennai
TAMIL NADU 
09677497399

sobika.sudhakar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri venkateswara dental college and hospital institute ethics commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K026||Dental caries on smooth surface,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Chlorhexidine mouthwash  5 ml of chlorhexidine mouthwash will be given to the patient and asked to rinse for 1 minute 
Intervention  Riboflavin (vitamin B2)  0.5% riboflavin solution is prepared and given to the patient to rinse the mouth for 1 minute and further it is activated using blue LED light 
Intervention  Riboflavin with surfactant  In riboflavin solution,0.01% sodium lauryl sulfate is added to enhance the agent to disrupt the bacteial cell 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  Good general health
Absence of systemic antibiotic intake at least 3 months prior to study,
Under fixed orthodontic treatment
Absence of oral lesions
Supragingival calculus
Severe malocclusion
Evident dental plaque accumulation.
 
 
ExclusionCriteria 
Details  The use of mouthwashes during the study and the follow-up,
Pregnancy
Systemic disorders
History of parafunctional and deleterious habits (tobacco chewing)
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Comparing the reduction of bacterial count among the experimental groups.
To find out the number of live and dead bacterias using confocal laser microscopy
 
T0 - Before application of test agents
T1- Immediately after application
T2 - 60 days after application
 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the percentage of live and dead bacterias using confocal laser scanning microscopy  T0,T1 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a Randomised, parallel, active controlled trial which compares the efficacy of 0.5% riboflavin in solution form and 0.12% chlorhexidine mouthwash given once a week for consecutively four weeks in 30 orthodontic patients who are undergoing treatment for the past 6 months. The primary outcome of the study will be comparing the reduction of bacterial count at T0 ( before application), T1 (Immediately after application, T2 ( 60 days from initial application). The secondary outcomes will be assessing the viability of bacterias using confocal laser scanning microscopy at T0 and T1. 
Close